Bora CDMO Bora CDMO

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Cyclopentylcytosine on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10130589
Y
2030-12-22
21829
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1272
21829
TREATMENT OF SIGNS AND SYMPTOMS OF PARKINSON'S DISEASE BY APPLICATION OF CLAIMED TRANSDERMAL SYSTEM
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246980
Y
2025-11-27
21829
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246980
Y
2025-11-27
21829
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1273
21829
TREATMENT OF RESTLESS LEGS SYNDROME BY APPLICATION OF CLAIMED TRANSDERMAL DELIVERY SYSTEM
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246980
Y
2025-11-27
21829
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1272
21829
TREATMENT OF SIGNS AND SYMPTOMS OF PARKINSON'S DISEASE BY APPLICATION OF CLAIMED TRANSDERMAL SYSTEM
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10350174
Y
2030-12-22
21829
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
9925150
Y
2032-03-01
21829
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10130589
Y
2030-12-22
21829
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
9925150
Y
2032-03-01
21829
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1273
21829
TREATMENT OF RESTLESS LEGS SYNDROME BY APPLICATION OF CLAIMED TRANSDERMAL DELIVERY SYSTEM
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
9925150
Y
2032-03-01
21829
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246980
Y
2025-11-27
21829
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1273
21829
TREATMENT OF RESTLESS LEGS SYNDROME BY APPLICATION OF CLAIMED TRANSDERMAL DELIVERY SYSTEM
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246980
Y
2025-11-27
21829
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1272
21829
TREATMENT OF SIGNS AND SYMPTOMS OF PARKINSON'S DISEASE BY APPLICATION OF CLAIMED TRANSDERMAL SYSTEM
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10350174
Y
2030-12-22
21829
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
9925150
Y
2032-03-01
21829
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10350174
Y
2030-12-22
21829
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10130589
Y
2030-12-22
21829
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10350174
Y
2030-12-22
21829
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1272
21829
TREATMENT OF SIGNS AND SYMPTOMS OF PARKINSON'S DISEASE BY APPLICATION OF CLAIMED TRANSDERMAL SYSTEM
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1273
21829
TREATMENT OF RESTLESS LEGS SYNDROME BY APPLICATION OF CLAIMED TRANSDERMAL DELIVERY SYSTEM
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10350174
Y
2030-12-22
21829
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
9925150
Y
2032-03-01
21829
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246980
Y
2025-11-27
21829
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
9925150
Y
2032-03-01
21829
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10130589
Y
2030-12-22
21829
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1273
21829
TREATMENT OF RESTLESS LEGS SYNDROME BY APPLICATION OF CLAIMED TRANSDERMAL DELIVERY SYSTEM
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10350174
Y
2030-12-22
21829
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1272
21829
TREATMENT OF SIGNS AND SYMPTOMS OF PARKINSON'S DISEASE BY APPLICATION OF CLAIMED TRANSDERMAL SYSTEM
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10130589
Y
2030-12-22
21829
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1273
21829
TREATMENT OF RESTLESS LEGS SYNDROME BY APPLICATION OF CLAIMED TRANSDERMAL DELIVERY SYSTEM
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
10130589
Y
2030-12-22
21829
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Belgium
Digital Content Digital Content
URL Supplier Web Content
8246979
Y
2027-09-01
U-1272
21829
TREATMENT OF SIGNS AND SYMPTOMS OF PARKINSON'S DISEASE BY APPLICATION OF CLAIMED TRANSDERMAL SYSTEM
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY